Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Intra-Cellular Ther
(NQ:
ITCI
)
73.02
-0.86 (-1.17%)
Streaming Delayed Price
Updated: 11:18 AM EDT, Aug 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Intra-Cellular Ther
< Previous
1
2
3
4
5
Next >
Biotech Stocks: Why Acadia Pharma And Others Are Feeling 'Growing Pains'
August 07, 2024
Acadia led a biotech selloff on Wednesday as Daybue sales missed expectations.
Via
Investor's Business Daily
Topics
Earnings
Exposures
Financial
Deep Dive Into Intra-Cellular Therapies Stock: Analyst Perspectives (9 Ratings)
August 07, 2024
Via
Benzinga
Revolutionary Magnetic Therapy Could Speed Up Bipolar Treatment
August 06, 2024
New research suggests that powerful magnets could effectively treat bipolar disorder. This therapy, which is known as accelerated intermittent theta burst stimulation (iTBS), uses magnetic waves...
Via
PressReach
Exposures
Product Safety
NVIDIA To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Monday
July 22, 2024
Via
Benzinga
A Closer Look at 11 Analyst Recommendations For Intra-Cellular Therapies
July 22, 2024
Via
Benzinga
Where Intra-Cellular Therapies Stands With Analysts
June 12, 2024
Via
Benzinga
China's Bilibili And Ollie's Bargain Outlet Were Among 10 Mid Cap Stocks With Biggest Gains In The Last Week (June 16-June 22, 2024): Are They In Your Portfolio?
June 23, 2024
Top performing mid-cap stocks last week: BILI (+23%), IBRX (+22%), SSL (+20%), OLLI (+15%), ITCI (+13%), AMKR (+12%), IRTC (+11%), RKLB (+11%), BFH (+10%), BRFS (+10%).
Via
Benzinga
Intra-Cellular Therapies Stock Scores RS Rating Upgrade To 87
June 20, 2024
Intra-Cellular Therapies sees its Relative Strength Rating enter the 80-plus level.
Via
Investor's Business Daily
Patterson Companies, Silk Road Medical, Micron, Hewlett Packard Enterprise And Other Big Stocks Moving Higher On Tuesday
June 18, 2024
Via
Benzinga
Intra-Cellular Therapies' Highlights Successful Data From Second Depression Study
June 18, 2024
Intra-Cellular Therapies reports positive topline results for Study 502 on lumateperone 42 mg as adjunctive therapy for major depressive disorder. FDA application expected in H2 2024.
Via
Benzinga
Exposures
Product Safety
Analyst Ratings For Intra-Cellular Therapies
May 08, 2024
Via
Benzinga
The Analyst Verdict: Intra-Cellular Therapies In The Eyes Of 14 Experts
April 22, 2024
Via
Benzinga
How Is The Market Feeling About Intra-Cellular Therapies?
April 19, 2024
Via
Benzinga
Intra-Cellular Therapies Eyes $1.7 Billion Opportunity After Phase 3 Win
June 18, 2024
The company hopes to expand its antipsychotic drug to depression treatment.
Via
Investor's Business Daily
The Secret Stock Stash: 3 Overlooked Picks That Belong in Every Portfolio
May 30, 2024
While it’s comforting to pick the ideas of the masses, these overlooked stocks may offer superior upside potential for the daring.
Via
InvestorPlace
ITCI Stock Earnings: Intra-Cellular Therapies Beats EPS, Beats Revenue for Q1 2024
May 07, 2024
ITCI stock results show that Intra-Cellular Therapies beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
3 Biotech Stocks With Skyrocketing Potential: April 2024
April 24, 2024
These three biotech stocks, with robust fundamentals and long-term prospects represent the sector’s finest at this time.
Via
InvestorPlace
Stock Market Sells Off; Taiwan Semi, ASML, Netflix, Tesla In Focus: Weekly Review
April 19, 2024
The Nasdaq and S&P 500 tumbled below their 50-day lines.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
8 Analysts Assess Intra-Cellular Therapies: What You Need To Know
April 03, 2024
Via
Benzinga
Where Intra-Cellular Therapies Stands With Analysts
February 23, 2024
Via
Benzinga
Abbott Laboratories, U.S. Bancorp And 3 Stocks To Watch Heading Into Wednesday
April 17, 2024
With U.S. stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 16, 2024
Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 16, 2024
Via
Benzinga
Intra-Cellular Stock Rallies On Successful Late-Stage Depression Treatment Study
April 16, 2024
Unlock new hope for major depressive disorder with Lumateperone 42 mg. Results from Intra-Cellular's Study 501, show significant symptom relief as adjunctive therapy to antidepressants.
Via
Benzinga
UnitedHealth Reports Upbeat Earnings, Joins Cullinan Oncology, Ericsson And Other Big Stocks Moving Higher On Tuesday
April 16, 2024
U.S. stocks were mostly higher, with the Dow Jones index gaining over 100 points on Tuesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Intra-Cellular Therapies Inc. (NASDAQ: ITCI) Climbs to New 52-Week High
April 16, 2024
Via
Investor Brand Network
Intra-Cellular Therapies Stock Launches 20% Into Breakout Territory On Depression Test Results
April 16, 2024
Intra-Cellular Therapies is trying to position its antipsychotic in depression treatment.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 16, 2024
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
April 04, 2024
Via
Benzinga
3 Biotech Stocks That Could Be Multibaggers in the Making: February Edition
February 21, 2024
Now could be the time to start looking into these biotech stocks as there are imminent approvals on their clinical trials.
Via
InvestorPlace
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.